Cashu
Aclaris Therapeutics: Summary Request for Content Needed for Analysis.
6 months ago
Stocks
Health Care
acrs
Aclaris Therapeutics
NASDAQ: ACRS
+1.80 (+68.70%)
4.42
USD
At close at Jan 20, 21:40 UTC
Overview
Loading chart...
Key Stats
Market Cap
479.91M
Dividend Yield
0.00%
P/E Ratio
-3.39
EPS
-1.71
Revenue
18.72M
Avg. Volume
9.10M
About
What does ACRS do?
Aclaris Therapeutics, a biopharmaceutical company based in Wayne, Pennsylvania, focuses on developing novel drugs for dermatology and immunology, with key candidates including ATI-1777 and Zunsemetinib. Founded in 2015, it employs 91 staff and utilizes its KINect platform for drug discovery.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.